SonarModel.PRO
{
  "id": "f3b1dc5c-d434-4e25-9480-43a3754b9689",
  "choices": [
    {
      "finish_reason": "stop",
      "index": 0,
      "logprobs": null,
      "message": {
        "content": "{\n  \"answer\": \"NO\",\n  \"note\": \"Indonesia does not directly accept the ICH CTD format for innovator pharmaceutical product registrations. Instead, Indonesia requires the use of the ASEAN Common Technical Dossier (ACTD) format, which is derived from the ICH CTD but has significant country-specific requirements and structural differences[1][2]. The ACTD is the agreed submission format for ASEAN nations, including Indonesia, and differs from the ICH CTD, notably by having four instead of five modules and generally requiring less extensive documentation in some areas[2]. Applicants seeking registration in Indonesia must comply with the ACTD format, incorporating specific national requirements as outlined by Indonesian regulations[1].\"\n}",
        "refusal": null,
        "role": "assistant",
        "annotations": null,
        "audio": null,
        "function_call": null,
        "tool_calls": null
      },
      "delta": {
        "role": "assistant",
        "content": ""
      }
    }
  ],
  "created": 1755676905,
  "model": "sonar-pro",
  "object": "chat.completion",
  "service_tier": null,
  "system_fingerprint": null,
  "usage": {
    "completion_tokens": 147,
    "prompt_tokens": 30,
    "total_tokens": 177,
    "completion_tokens_details": null,
    "prompt_tokens_details": null,
    "search_context_size": "low",
    "cost": {
      "input_tokens_cost": 0.0,
      "output_tokens_cost": 0.002,
      "request_cost": 0.006,
      "total_cost": 0.008
    }
  },
  "citations": [
    "https://journalforclinicalstudies.com/wp-content/uploads/2015/02/09.-Comparison-of-Marketing-Authorisation.pdf",
    "https://international-pharma.com/wp-content/uploads/2017/04/Comparison-of.pdf",
    "https://ijprajournal.com/issue_dcp/A%20Review%20Article%20on%20the%20Common%20Technical%20Document%20CTD%20Regulatory%20Dossier.pdf",
    "https://www.ema.europa.eu/en/documents/scientific-guideline/ich-guideline-m4-r4-common-technical-document-ctd-registration-pharmaceuticals-human-use-organisation-ctd-step-5_en.pdf",
    "https://www.ijpcbs.com/articles/comparative-study-of-regulatory-requirementsfor-the-compilation-and-approval-of-dossieras-per-ctd-actd-and-ectd-formats.pdf"
  ],
  "search_results": [
    {
      "title": "[PDF] Comparison of Marketing Authorisation and its Requirements for ...",
      "url": "https://journalforclinicalstudies.com/wp-content/uploads/2015/02/09.-Comparison-of-Marketing-Authorisation.pdf",
      "date": null,
      "last_updated": "2025-05-02"
    },
    {
      "title": "[PDF] Comparison of Marketing Authorisation and its Requirements for ...",
      "url": "https://international-pharma.com/wp-content/uploads/2017/04/Comparison-of.pdf",
      "date": null,
      "last_updated": "2025-05-08"
    },
    {
      "title": "[PDF] A Review Article on the Common Technical Document (CTD ...",
      "url": "https://ijprajournal.com/issue_dcp/A%20Review%20Article%20on%20the%20Common%20Technical%20Document%20CTD%20Regulatory%20Dossier.pdf",
      "date": "2025-05-05",
      "last_updated": "2025-05-13"
    },
    {
      "title": "[PDF] ICH guideline M4 (R4) on common technical document (CTD) for the ...",
      "url": "https://www.ema.europa.eu/en/documents/scientific-guideline/ich-guideline-m4-r4-common-technical-document-ctd-registration-pharmaceuticals-human-use-organisation-ctd-step-5_en.pdf",
      "date": null,
      "last_updated": "2025-08-10"
    },
    {
      "title": "[PDF] AS PER CTD, ACTD AND ECTD FORMATS",
      "url": "https://www.ijpcbs.com/articles/comparative-study-of-regulatory-requirementsfor-the-compilation-and-approval-of-dossieras-per-ctd-actd-and-ectd-formats.pdf",
      "date": null,
      "last_updated": "2025-04-29"
    }
  ]
}